Clin2
NCT07220694Possibly a fitRecruiting

Sabroxy supplement for memory and insulin resistance

Insulin ResistanceMild Cognitive ImpairmentCognitive DeclineNeurodegenerative Disorders

Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.

This study tests whether a supplement called Sabroxy can improve insulin resistance and memory in adults with mild cognitive impairment and insulin resistance. It may help if you have early memory problems and your blood sugar is slightly higher than normal.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
140 people
Ages
40 years to 80 years
Study type
Interventional

Who can take part

  • You are between 40 and 80 years old.
  • You have a blood test showing insulin resistance (HOMA-IR score between 2.0 and 4.0) and a fasting blood sugar between 100 and 135 mg/dL.
  • You have mild memory problems (a MoCA score below 26).
  • You are generally in good health, without uncontrolled medical conditions like diabetes, severe depression, or recent heart problems.
  • You are not pregnant, breastfeeding, or planning pregnancy, and are not taking medications that affect blood sugar or immune system.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06072963Recruiting· Phase 2
Combining insulin and semaglutide for memory in MCI with metabolic syndrome

This study tests if a combination of insulin and semaglutide (a diabetes drug) can improve memory and thinking in people with mild cognitive impairment (MCI) who also have metabolic syndrome (a cluster of health issues like large waist, high blood sugar, and high blood pressure). It aims to see if treating blood sugar problems helps protect the brain.

Ramat Gan
NCT07083154Recruiting· Phase 3
Testing a dual-action drug for diabetes and early memory loss

This study tests if a new type of diabetes drug that targets two natural hormones can help people with type 2 diabetes who also have early memory problems. If you have type 2 diabetes and mild cognitive impairment or mild dementia, this trial may offer a potential treatment option.

Changsha, Hunan
NCT07226674Recruiting
Study of gut health and plant nutrients for brain health

This trial tests whether a natural plant compound can help support memory and thinking in people at higher risk for Alzheimer's disease. You may qualify if you are over 50, overweight, eat a typical Western diet, and have a family history of Alzheimer's.

Coleraine
NCT06830824Not yet recruiting
Inulin and probiotics for older adults with diabetes

This trial tests if taking a dietary fiber (inulin) plus a probiotic (L. acidophilus) can help improve memory and thinking in older adults with type 2 diabetes who already have some cognitive issues.

NCT07000500Enrolling by invitation
Nutritional supplement for memory decline in older adults

This trial tests whether a nutritional supplement can help slow or improve memory loss in older adults who have mild cognitive decline (noticeable changes in thinking skills that are not yet dementia). You will take a daily supplement and attend regular check-ups.

Vila Nova de Famalicão, Braga District
NCT07711171Recruiting· Phase 4
Canagliflozin for type 2 diabetes with mild memory problems

This trial tests whether the diabetes drug canagliflozin can help people with type 2 diabetes and mild cognitive impairment. It may slow down memory and thinking problems while also improving blood sugar control.

Shanghai, Shanghai Municipality

Hear when a new Insulin Resistance trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.